Skip to main content
logo
Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
1.400
+0.030 (2.19%)
Jul 31, 2026, 4:00 PM EDT - Market closed

Purple Biotech Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-28.3-27.46-11.01-22.27-22.6-17.93
Net Income
-26.02-26.39-7.24-19.88-21.67-18.38
Earnings Per Share
-205.91-54.00-44.00-178.0023.971.01
EPS Growth
----2273.27%-59.60%

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
6.439.578.5215.4132.1147.2
Total Debt
0.180.240.180.350.520.75
Net Cash (Debt)
6.249.338.3415.0631.646.45
Net Cash Growth
-10.19%11.86%-44.62%-52.34%-31.98%-18.38%
Net Cash Per Share
8.7619.4450.87136.0934.954.04

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-6.8-5.66-14.37-19.93-16.74-14.88
Capital Expenditures
--0--0-0.03-0.12
Free Cash Flow
-6.8-5.66-14.37-19.93-16.76-14.99
Free Cash Flow Growth
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----1.1577.03